(Washington, D.C.): Earlier today, the Department of Justice under the Trump Administration requested a federal court to pause the case in Louisiana v. FDA and deny the client immediate relief pending the Food and Drug Administration (FDA) review of the abortion pill, mifepristone. There is no public evidence that this review is actively being conducted. Sarah Zagorski, Senior Director of Public Relations & Communications for Americans United for Life […] The post Trump DOJ Asks for Delay in Essential Abortion Pill Case, Pending FDA Review with No Deadline appeared first on Americans United fo
Read →Loading search…